Clinical Trials Browser

Withdrawn × GSK2110183 × Other hematologic neoplasm × Clear all

NCT01445587 2012-03-26

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Phase 2 Withdrawn

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms